EFFICACY OF INTRAVESICAL NADOFARAGENE FIRADENOVEC FOR PATIENTS WITH BCG-UNRESPONSIVE CARCINOMA IN SITU OF THE BLADDER: 36-MONTH FOLLOW-UP FROM A PHASE 3 TRIAL
Titel:
EFFICACY OF INTRAVESICAL NADOFARAGENE FIRADENOVEC FOR PATIENTS WITH BCG-UNRESPONSIVE CARCINOMA IN SITU OF THE BLADDER: 36-MONTH FOLLOW-UP FROM A PHASE 3 TRIAL
Auteur:
Boorjian, Stephen A. Narayan, Vikram M. Master, Viraj A. Konety, Badrinath R. Shore, Neal D. Kamat, Ashish M. Dinney, Colin P.N. Bivalacqua, Trinity J. Kates, Max R. Montgomery, Jeffrey S. Lerner, Seth P. Crispen, Paul L. Steinberg, Gary D. Agarwal, Piyush K. Schuckman, Anne K. Svatek, Robert S. Lane, Brian R. Karsh, Lawrence I. Bjurlin, Marc A. Brown, Gordon A. Lotan, Yair Inman, Brant A. Williams, Michael B. Cookson, Michael S. Chang, Sam S. Kim, Eric H. Sankin, Alexander I. O'Donnell, Michael A. Jakobsen, Jørn S. Juul, Kristian